Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The aim of this study is to evaluate whether Dabigatran itself reduces ADP induced platelet aggregation measured by MEA as compared to Phenprocoumon after a two-week treatment with either agent.
Epistemonikos ID: 3df822d107fe199911ab197742e9f5f85405dec9
First added on: May 06, 2024